PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C0011860|type 2 diabetes mellitus |
| Sentences | 38 |
| PubMedID- 25253014 | Conclusion: the systolic longitudinal myocardial function of lv become compromised before reduced lv global systolic function in coronary atherosclerosis patients with type 2 diabetes mellitus. |
| PubMedID- 23904855 | In this study, the total number for atherosclerosis in patients with type 2 diabetes mellitus increased with the progression of renal dysfunction. |
| PubMedID- 20194881 | Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. |
| PubMedID- 20923475 | However, the association between prehypertension and atherosclerosis in type 2 diabetes mellitus (t2dm) has not been evaluated. |
| PubMedID- 23387219 | [the correlation of serum cystatin c level with the severity of carotid atherosclerosis in patients with type 2 diabetes mellitus]. |
| PubMedID- 22330623 | The gstt1-0 genotype and gstt1-0/gstm1-0 haplotype might be a potential determinants of susceptibility to advanced atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 20593206 | The objective of this study is to investigate the correlation of urinary albumin excretion rate (uaer) with the incidence of coronary heart disease (chd), pathological characteristics and severity of coronary atherosclerosis in patients with type 2 diabetes mellitus (t2dm), and explore the efficacy of using the urinary albumin excretion rate (uaer) to predict the risk of chd in patients with t2dm. |
| PubMedID- 21996253 | Aims: to analyze the relationship between serum levels of osteocalcin and parameters of atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 26505665 | Method: this case-control study included 596 type 2 diabetes mellitus patients with carotid atherosclerosis and 379 patients without carotid atherosclerosis. |
| PubMedID- 21227528 | Association of serum trail levels with atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 21779189 | Recently, 2 adipocytokines, leptin and adiponectin, have been recognized as key regulators of various metabolic disorders, and the serum/plasma leptin:adiponectin ratio (l:a) has been reported to be a new surrogate marker for atherosclerosis in subjects with obesity and type 2 diabetes mellitus [6, 7]. |
| PubMedID- 24551481 | Association between framingham risk score and subclinical atherosclerosis among elderly with both type 2 diabetes mellitus and healthy subjects. |
| PubMedID- 23573090 | Assessment of carotid atherosclerosis in type 2 diabetes mellitus patients with microalbuminuria by high-frequency ultrasonography. |
| PubMedID- 21894292 | Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. |
| PubMedID- 20207378 | [usefulness of pulse oximetry in screening of carotid atherosclerosis in patients with type 2 diabetes mellitus]. |
| PubMedID- 25708055 | In conclusion, cumulative active and passive smoking exposures are significant risk factors for carotid atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 24739810 | Increased levels of adma were found in the development of carotid atherosclerosis in patients with type 2 diabetes mellitus (t2dm) [22], in subjects with early asymptomatic carotid atherosclerosis [23], and especially in patients with chronic kidney disease (ckds) and rheumatoid arthritis [24]. |
| PubMedID- 25369080 | Background: the genetic background of atherosclerosis in type 2 diabetes mellitus (t2dm) is complex and poorly understood. |
| PubMedID- 25975128 | [a relationship between cardiac structural and functional parameters, left ventricular contractility, and coronary atherosclerosis in patients with type 2 diabetes mellitus]. |
| PubMedID- 25120969 | Effect of age and blood pressure on surrogate markers of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 22368195 | Aims: several studies have demonstrated that type 2 diabetes mellitus (t2dm) is associated with accelerated atherosclerosis, which results in an increased risk of coronary vascular events. |
| PubMedID- 26069232 | Little data exist about the relationship of apoc-iii, triglycerides, and atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24607023 | Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using dpp-4 inhibitor: the sitagliptin preventive study of intima-media thickness evaluation (spike). |
| PubMedID- 24678948 | The aim of this study was to investigate the relationships of subcutaneous and visceral abdominal fat with carotid atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24423050 | The gstt1-null genotype and combined gstt1*0/gstm1*0 might be potential determinants of susceptibility to advanced atherosclerosis in patients with type 2 diabetes mellitus [16]. |
| PubMedID- 20004424 | We investigated the relationship between hemoglobin concentration and various factors as well as markers of subclinical atherosclerosis in men with type 2 diabetes mellitus. |
| PubMedID- 23574730 | Postprandial hyperglycemia and/or hyperlipidemia can contribute to development of atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 26251624 | The development of atherosclerosis in patients with type 2 diabetes mellitus (t2dm) may be due to hypercoagulability and platelet hyperaggregability,1,2 along with increased levels of platelet activation markers. |
| PubMedID- 22333479 | High serum levels of s100a8/a9 are associated with acute coronary syndrome and atherosclerosis in type 2 diabetes mellitus (t2dm). |
| PubMedID- 25589482 | Given the multi-faceted pathogenesis of atherosclerosis in type 2 diabetes mellitus (t2dm), it is likely that interventions to mitigate this risk must address cardiovascular (cv) risk factors beyond glucose itself. |
| PubMedID- 24988089 | This might be one of the causal pathogenic factors initiating accelerated atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 20516379 | The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the diabetic atherosclerosis prevention by cilostazol (dapc) study: a randomized trial. |
| PubMedID- 20686328 | The correlation between cvr-r and carotid atherosclerosis in type 2 diabetes mellitus patients with diabetic neuropathy. |
| PubMedID- 25953645 | Conclusions: the plasma level of mmp-7 and -12 are elevated in type 2 diabetes mellitus, associated with more severe atherosclerosis and an increased incidence of coronary events. |
| PubMedID- 20361178 | This pathogenic sequence establishes the molecular basis linking insulin resistance, inflammation and accelerated atherosclerosis in people with type 2 diabetes mellitus and may help account for the missing 30% cvd risk that cannot be explained by circulating cardiovascular risk factors [74, 76] (fig. |
| PubMedID- 25851542 | [33] suggested that ga was a more valuable index than hba1c for predicting the progression of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 23337395 | Aim: to evaluate the expression of atherosclerosis-associated genes in patients with hypertension and type 2 diabetes mellitus. |
| PubMedID- 21483695 | Part of the increased susceptibility to atherosclerosis of patients with type 2 diabetes mellitus and the metabolic syndrome has been attributed to the decreased clearance of trps [5], [31], [32]. |
Page: 1